A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 2b study of OTO-104 given as a single intratympanic injection in subjects with unilateral Menieres disease (104-201102)
Clinical Trial Grant
Administered By
Head and Neck Surgery & Communication Sciences
Awarded By
Otonomy, Inc.
Start Date
April 1, 2014
End Date
December 16, 2015
Administered By
Head and Neck Surgery & Communication Sciences
Awarded By
Otonomy, Inc.
Start Date
April 1, 2014
End Date
December 16, 2015